emerging glp-1 gip treatments 2025 research on metabolic therapies in 2025–2026 show major advances with newer drugs targeting multiple metabolic pathways. , Triple-receptor agonists like retatrutide, which act on GLP-1, GIP, What is the pipeline for

A recent Lancet Commission proposed an obesity definition that integrates body mass index (BMI [calculated as weight in kilograms divided by height in meters squared]) with anthropometric measures, marking a paradigm shift in how obesity is conceptualized and classified

Youll gain skills to navigate the psychological, identity, and emotional shifts clients experiencelike perfectionism, fear of regain, and shameso you can meet them with empathy and strategy

prepared the data, conducted the statistical analysis, and made the figures and tables

Fernando Ovalle Jr., a Florida-based obesity medicine specialist

Materials and methods This study was designed following the framework delineated by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [17] with rigorous attention given to registering the study protocol in the International Prospective Register for Systematic Reviews (PROSPERO) (registration code: CRD42023466256)

In the 30-second ad campaign, Williams stresses that taking GLP-1s is not a shortcut, its science